Canada Markets open in 8 hrs 23 mins

Helix BioPharma Corp. (HBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.5400-0.0100 (-1.82%)
At close: 3:59PM EDT
Full screen
Previous Close0.5500
Open0.5300
Bid0.5100 x 0
Ask0.5400 x 0
Day's Range0.5100 - 0.5400
52 Week Range0.2500 - 1.1600
Volume6,016
Avg. Volume10,430
Market Cap76.212M
Beta (5Y Monthly)-0.19
PE Ratio (TTM)N/A
EPS (TTM)-0.0550
Earnings DateMar. 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.10
  • ACCESSWIRE

    Helix BioPharma Corp. Announces Delay of Annual Filings

    RICHMOND HILL, ON / ACCESSWIRE / October 15, 2021 / Helix BioPharma Corp.In light of the Company's recent change of auditor, previously announced on June 24, 2021 and the departure of the Company's long tenured CEO & CSO effective September 1, 2021, in order to ensure that all internal and audit controls are properly executed, the Company has determined that it will not be able to complete the audit and file the Annual Filings by the Filing Deadline.

  • ACCESSWIRE

    Helix BioPharma Corp. Announces Appointment of Interim Chief Executive Officer

    RICHMOND HILL, ON / ACCESSWIRE / September 20, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the Company's Chairman of the Board, Prof.

  • ACCESSWIRE

    Helix BioPharma Corp. Announces Appointment of New Director

    RICHMOND HILL, ON / ACCESSWIRE / August 19, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that Dr.